<DOC>
	<DOCNO>NCT02281838</DOCNO>
	<brief_summary>The vast majority intracerebral hemorrhage ( ICH ) patient present elevate blood pressure ( BP ) . Management BP controversial two compete rationale . There evidence hyperacute treatment may improve outcome reduce rate hematoma expansion . Physicians reluctant reduce BP early ICH onset , fear reduce cerebral blood flow ( CBF ) increase ischemia increase risk damage . Other confound mediator ischemic injury follow ICH include increased platelet activity , withdrawal antithrombotic therapy , endothelial dysfunction , inflammation hypercoagulability . This study phase II ICH-ADAPT study . The investigator hypothesize aggressive antihypertensive therapy alter natural history heamatoma growth , improve outcome Intracranial Hemorrhage ( ICH ) . The previous phase I ICH-ADAPT study establish safety early BP treatment . The investigator design phase II study ICH patient randomize aggressive versus conservative BP treatment use deferred consent procedure . An adaptive randomization use treat BP &lt; 140 mmHg SBP &lt; 180 mmHg SBP . Treatment must implement soon possible radiological confirmation diagnosis . Antihypertensive therapy must begin within 6 hour symptom onset . The patient re-imaged 24 hour later . The patient continuous non-invasive BP heart rate ( HR ) monitor minimum 24 hour . Antihypertensive drug use dosage record BP HR . Patients monitor regularly study completion . MRI 's do 48 hour , day 7 day 30 . This image help detect ischemic change may occur . Blood collect time MRI . Blood analysis do possibly identify biomarkers may putative mediator ischemic injury ICH patient .</brief_summary>
	<brief_title>The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II</brief_title>
	<detailed_description>Study Design : multi-centre randomized open-label , blinded-endpoint trial two different BP management strategy . This study conduct Emergency Departments Stroke Units Canadian academic non-academic centre . Overall Aim Hypothesis : The primary study aim ass rate ischemic lesion development patient randomize two different BP treatment strategy . The overall priori hypothesis aggressive BP reduction associate ischemic injury ICH . Patients : Male female patient recruit Emergency Departments participate hospital . A total 270 patient include 3 year . Baseline Data Randomization : Demographics , Glasgow Coma Scale ( GCS ) National Institutes Health Stroke Scale ( NIHSS ) score ( part routine stroke patient assessment ) , time symptom onset diagnostic CT scan record . If CT scan complete within 6 hour onset confirms evidence primary ICH , patient randomize . Where patient incompetent surrogate decision maker immediately available , randomization occur use deferred consent procedure . Stroke risk factor , past medical history medication , emphasis antihypertensive , well standard clinical blood work ( complete blood count coagulation profile ) record randomization order avoid delay BP treatment . Intervention - Blood Pressure Management Protocols : `` Aggressive '' BP Target ( &lt; 140 mmHg ) Treatment Group : Patients randomize &lt; 140 mmHg group ( n=135 ) immediately receive 10 mg IV bolus labetalol , administer 1 minute . A protocol design achieve maintain systolic BP &lt; 140 mmHg within 60 minute randomization design ( Appendix 5 ) . A key feature protocol utilization IV enalapril , give regularly ( Q . 6 hourly ) , avoid BP fluctuation , problem note previously use bolus-based protocols.109 Patients randomize &lt; 140 mmHg group treat 1.25 mg IV enalapril immediately labetalol administration . A low limit 120 mmHg stipulate , although give investigator experience ICH ADAPT I , unlikely achieve . In event systolic BP fall 120 mmHg , antihypertensive therapy hold patient fluid resuscitate isotonic saline . Pressor agent use . `` Conservative '' BP Target ( &lt; 180 mmHg ) Treatment Group : Patients randomize &lt; 180 mmHg group ( n=135 ) administer parenteral antihypertensive therapy systolic BP ≥180 mmHg , consistent current guideline . All patient continuous non-invasive BP heart rate ( HR ) monitor minimum 24h . BP HR record intensively hyperacute phase , per NINDS r-tPA protocol vital sign monitoring . Antihypertensive drug use dosage record concomitantly BP HR . Patients monitor regularly study completion . Door-to-needle time documented respect initiation antihypertensive medication proportion patient achieve BP target within 1 hour treatment . At completion 24h active treatment period , patient continue receive standard stroke care rehabilitation , treat physician manage BP manner feel appropriate . Physicians encourage start oral antihypertensive therapy , administer via nasogastric feed tube necessary , day 2 . BP , HR antihypertensive medication dos continue monitor record every 4 h first 48 h twice daily discharge . Long-term goal patient group active treatment period systolic BP &lt; 140 mmHg , &lt; 130 mmHg diabetes , per current stroke prevention hypertension guideline . Imaging Procedures : Baseline - Immediately prior randomization BP reduction , patient undergo standard non-contrast CT diagnostic brain scan . In event early neurological deterioration point , repeat CT scan obtain immediately . 24 hour CT - All patient repeat CT brain scan 24±3 h , order ass hematoma expansion peri-hematoma edema volume . 48 hour MRI - At 48±12 h , patient undergo MRI scanning , include T1-weighted sagittal localizer , DWI , Gradient Recalled Echo ( GRE ) /Susceptibility Weighted Imaging ( SWI ) , diffusion-weighted ( DWI ) perfusion-weighted image ( PWI ) . Day 7 MRI Scan ( Secondary Endpoint ) - A repeat MRI obtain 7±2 day assess new DWI lesion development evolution identify 24 hour . Day 30 MRI Scan ( Secondary Endpoint ) - A repeat MRI obtain 30±5 day assess new DWI lesion development evolution identify 24 hour 7 day . Clinical Assessments : In Hospital - In addition BP data , GCS NIHSS score collect event early neurological deterioration . Both score also record time MRI scan hospital discharge transfer alternate level care , i.e . rehabilitation long-term care facility . Discharge modify Rankin Scores ( mRS ) also record . Cognitive change assess Montreal Cognitive Assessment ( MoCA ) time MRI scan . Follow-up ( Day 30 ) - A standardized interview aim determine mortality current residence patient ( home/hospital/rehabilitation hospital/long-term care facility ) administer time day 30 MRI . The NIHSS MoCA score also record , modify Rankin scale ( mRS ) score . Quality life assess EQ-5D . ( Day 90 ) - This standard time point measure functional outcome stroke trial , bulk neurological recovery occurs within time frame . All neurological , functional cognitive disability test repeat time .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<criteria>Age ≥18 year Acute primary ICH demonstrate CT scan , within 6 h symptom onset . Two systolic BP measurement ≥140 mmHg record &gt; 2 min apart qualify enrolment . Onset ≤ 24 h prior randomization Contraindication BP reduction i.e. , severe arterial stenosis highgrade stenotic valvular heart disease Indication urgent BP reduction i.e. , hypertensive encephalopathy , aortic dissection Definite evidence ICH secondary underlying cerebral vascular pathology , i.e. , AVM , aneurysm , tumour , trauma , vasculitis , hemorrhagic transformation ischemic infarct Previous ischemic stroke within 90 day current event NB : Prior ICH exclusion criterion Patients suspect secondary cause ICH . Planned surgical resection hematoma NB : Extraventricular Drain placement exclusion criterion Contraindication CT perfusion imaging ( i.e . contrast allergy , metformin use Creatinine &gt; 160 μmol/l ) Patients preexist disability dependence ( define premorbid modify Rankin Scale score ≥3 ) exclude Patients life expectancy &lt; 6 month due premorbid conditions/terminal illness Patients know definite contraindication MRI ( pacemaker , ferrous metallic foreign body )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Hypertension</keyword>
</DOC>